Esanik Therapeutics, Inc.
Pharmaceuticals · Northville, MI
PharmaceuticalsSEC Form D
Esanik Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 30, 2026, reporting $200,000 raised toward a $375,000 offering.
Incorporated in Delaware and based in Northville, MI, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Esanik Therapeutics, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- John Mel SorensenExecutive Officer · Director
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised